6.6.2017 09:03 | Business Wire
Duco Doubles Revenue and Expands Global Footprint
Duco , the global provider of self-service data normalization and reconciliation services, today gave an update on its year-end results. Highlights include well over 100% growth in annually recurring revenue (ARR), a 50% increase in new clients, and significant development of the firm’s flagship reconciliation platform Duco Cube . Alongside this, Duco increased its footprint in New York and London, adding key senior management and personnel focused on research and development, client services and commercial expansion. By using Duco Cube, clients have saved over 5000 man hours per day in manual reconciliation time.
Demand for Duco Cube was driven by firms wanting to reduce costs, eliminate manual controls and address data challenges with legacy systems. Business in the UK and Europe saw growth due to regulatory requirements for EMIR, MiFID and the upcoming MiFID II , alongside supporting system migration activities. US growth was fueled by take-up in listed derivatives and the buy side. At the macro level, Duco benefitted from Software as a Service (SaaS) platforms becoming a mainstream option for the financial services industry.
The company extended its strategic agreements with several existing clients and made a number of key wins across global banks, brokers and buy side firms. In addition, Duco expanded into new industry verticals, signing a major international distribution agreement with CME Group, as well as new commercial deals with fund administrators and payments firms. The company also extended its global support structure, setting up a data center in Luxembourg following the deployment of Duco Cube for Societe Generale Bank & Trust. This continues to fuel Duco’s investment and international expansion strategy.
Christian Nentwich, CEO of Duco, said: “We have had yet another strong year and Duco is well positioned for further growth. As cost pressures, upcoming regulation and the search for efficiency continue to shape the industry, there is an ongoing shift from legacy processes to using agile, quick-to-deploy technology. We continue to set the standard in this space with a SaaS-based platform that’s live in 24 hours from contract signature, with return on investment in 30 days. Only Duco provides a self-service reconciliation tool that truly puts business users in control.”
Duco’s mission is to make managing data easy. As the market leader in self-service reconciliation, Duco empowers users to deal with complex data in a fraction of the time required by traditional systems. New clients are live in 24 hours, with reconciliations in production in 7 days and return on investment in 30 days. Customers include international banks, brokers, exchanges, hedge funds, asset managers, fund administrators, payments companies and corporates. Headquartered in London, with offices in New York and Luxembourg, Duco serves clients throughout Europe, the United States, Africa, Asia, the Middle East and Australia.
+44 (0)203 111 9294
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Ved at skrive dig op her, vil du modtage pressemeddelelser på mail når de udsendes. Indtast din mail og følg instruktionerne. Det er ligeså let at melde sig fra igen.
Flere pressemeddelelser fra Business Wire
NY-MOODY’S24.7.2017 16:02 | pressemeddelelse
Moody’s Analytics Voted Best Credit Risk Solution Provider in Waters Rankings for Second Year in a Row
SYNECTICS24.7.2017 16:01 | pressemeddelelse
Synectics Wins European Contract for Train-to-Ground ‘Passenger Help’ Solution
NY-CALVIN-KLEIN24.7.2017 15:02 | pressemeddelelse
Calvin Klein, Inc. Announces Fall 2017 CALVIN KLEIN 205W39NYC Global Advertising Campaign
SAMSUNG-BIOEPIS24.7.2017 14:06 | pressemeddelelse
Samsung Bioepis Announces RENFLEXIS™ (infliximab-abda) Now Available in the United States
MAVENIR24.7.2017 12:02 | pressemeddelelse
Mavenir Announces R & D Center of Excellence Focused on 5G Network and Services
CA-GILEAD-SCIENCES,-INC.24.7.2017 11:08 | pressemeddelelse
Gilead Announces Phase 3 Results for Investigational Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for Treatment of HIV
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum